| Cancer detection rates of the PI-RADSv2. 1 assessment categories: systematic review and meta-analysis on lesion level and patient level B Oerther, H Engel, F Bamberg, A Sigle, C Gratzke, M Benndorf Prostate cancer and prostatic diseases 25 (2), 256-263, 2022 | 79 | 2022 |
| ARP3 controls the podocyte architecture at the kidney filtration barrier C Schell, B Sabass, M Helmstaedter, F Geist, A Abed, ... Developmental cell 47 (6), 741-757. e8, 2018 | 44 | 2018 |
| Intraprostatic tumor segmentation on PSMA PET images in patients with primary prostate cancer with a convolutional neural network D Kostyszyn, T Fechter, N Bartl, AL Grosu, C Gratzke, A Sigle, M Mix, ... Journal of Nuclear Medicine 62 (6), 823-828, 2021 | 37 | 2021 |
| Artificial intelligence in magnetic resonance imaging–based prostate cancer diagnosis: where do we stand in 2021? R Suarez-Ibarrola, A Sigle, M Eklund, D Eberli, A Miernik, M Benndorf, ... European Urology Focus 8 (2), 409-417, 2022 | 27 | 2022 |
| Comparison of Manual and Semi-Automatic [18F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary … SKB Spohn, M Kramer, S Kiefer, P Bronsert, A Sigle, ... Frontiers in oncology 10, 600690, 2020 | 26 | 2020 |
| Srgap1 controls small rho gtpases to regulate podocyte foot process maintenance M Rogg, JI Maier, R Dotzauer, N Artelt, O Kretz, M Helmstädter, A Abed, ... Journal of the American Society of Nephrology 32 (3), 563-579, 2021 | 22 | 2021 |
| The impact of the co-registration technique and analysis methodology in comparison studies between advanced imaging modalities and whole-mount-histology reference in primary … C Zamboglou, M Kramer, S Kiefer, P Bronsert, L Ceci, A Sigle, ... Scientific reports 11 (1), 5836, 2021 | 21 | 2021 |
| Safety and side effects of transperineal prostate biopsy without antibiotic prophylaxis A Sigle, R Suarez-Ibarrola, M Pudimat, J Michaelis, CA Jilg, A Miernik, ... Urologic Oncology: Seminars and Original Investigations 39 (11), 782. e1-782. e5, 2021 | 19 | 2021 |
| Comprehensive analysis of complications after transperineal prostate biopsy without antibiotic prophylaxis: results of a multicenter trial with 30 days’ follow-up T Kohl, A Sigle, T Kuru, J Salem, H Rolfs, T Kowalke, R Suarez-Ibarrola, ... Prostate cancer and prostatic diseases 25 (2), 264-268, 2022 | 16 | 2022 |
| The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy—a … SKB Spohn, A Farolfi, S Schandeler, MME Vogel, J Ruf, M Mix, S Kirste, ... European Journal of Nuclear Medicine and Molecular Imaging 50 (1), 218-227, 2022 | 15 | 2022 |
| 99mTc-labelled PSMA ligand for radio-guided surgery in nodal metastatic prostate cancer: proof of principle M Mix, W Schultze-Seemann, M von Büren, A Sigle, MA Omrane, ... EJNMMI research 11, 1-9, 2021 | 13 | 2021 |
| Influence of urethra sparing on tumor control probability and normal tissue complication probability in focal dose escalated hypofractionated radiotherapy: a planning study … SKB Spohn, I Sachpazidis, R Wiehle, B Thomann, A Sigle, P Bronsert, ... Frontiers in Oncology 11, 652678, 2021 | 12 | 2021 |
| Incidental prostate cancer after holmium laser enucleation of the prostate—A narrative review M Yilmaz, T Toprak, R Suarez‐Ibarrola, A Sigle, C Gratzke, A Miernik Andrologia 54 (3), e14332, 2022 | 11 | 2022 |
| Morcellation after endoscopic enucleation of the prostate: efficiency and safety of currently available devices J Franz, R Suarez-Ibarrola, P Pütz, A Sigle, L Lusuardi, C Netsch, ... European Urology Focus 8 (2), 532-544, 2022 | 11 | 2022 |
| Experimental ex-vivo performance study comparing a novel, pulsed thulium solid-state laser, chopped thulium fibre laser, low and high-power holmium: YAG laser for endoscopic … M Yilmaz, J Esser, L Kraft, R Petzold, A Sigle, C Gratzke, ... World journal of urology, 1-6, 2022 | 9 | 2022 |
| Tyrosine Kinase Inhibitors in the Treatment of Metastasised Renal Cell Carcinoma—Future or the Past? J Michaelis, M Grabbert, A Sigle, M Yilmaz, D Schlager, C Gratzke, ... Cancers 14 (15), 3777, 2022 | 8 | 2022 |
| Prediction of significant prostate cancer in equivocal magnetic resonance imaging lesions: a high-volume international multicenter study A Sigle, A Borkowetz, J von Hardenberg, M Drerup, K Kornienko, J Kwe, ... European Urology Focus 9 (4), 606-613, 2023 | 7 | 2023 |
| Robotics and intraoperative navigation DS Schoeb, J Rassweiler, A Sigle, A Miernik, C Engels, AS Goezen, ... Der Urologe 60, 27-38, 2021 | 7 | 2021 |
| Prediction of upgrade to clinically significant prostate cancer in patients under active surveillance: Performance of a fully automated AI‐algorithm for lesion detection and … B Oerther, H Engel, A Nedelcu, CL Schlett, R Grimm, H von Busch, ... The Prostate 83 (9), 871-878, 2023 | 6 | 2023 |
| Isotropic expansion of the Intraprostatic gross tumor volume of primary prostate cancer patients defined in MRI—A correlation study with whole Mount histopathological … M Kramer, SKB Spohn, S Kiefer, L Ceci, A Sigle, B Oerther, ... Frontiers in Oncology 10, 596756, 2020 | 5 | 2020 |
